Vol 75, No 3 (2024)
Clinical vignette
Published online: 2024-06-06

open access

Page views 72
Article views/downloads 2
Get Citation

Connect on Social Media

Connect on Social Media

Treatment of parathormone-dependent hypercalcaemia in the third-trimester of pregnancy

Mateusz Zamłyński1, Anita Olejek1, Grzegorz Buła2, Adrianna Marzec1, Agata Gawrychowska3, Jacek Gawrychowski2
DOI: 10.5603/ep.99387
Pubmed: 38887118
Endokrynol Pol 2024;75(3):336-337.

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet. 2018; 391(10116): 168–178.
  2. Ali DS, Dandurand K, Khan AA. Primary Hyperparathyroidism in Pregnancy: Literature Review of the Diagnosis and Management. J Clin Med. 2021; 10(13).
  3. Norman J, Politz D, Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol (Oxf). 2009; 71(1): 104–109.
  4. McCarthy A, Howarth S, Khoo S, et al. Management of primary hyperparathyroidism in pregnancy: a case series. Endocrinol Diabetes Metab Case Rep. 2019 [Epub ahead of print]; 2019.
  5. Sandler ML, Ho R, Xing MH, et al. Primary Hyperparathyroidism During Pregnancy Treated With Parathyroidectomy: A Systematic Review. Laryngoscope. 2021; 131(8): 1915–1921.